Praluzatamab Reference: HY-P99788 Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers.
oYo-Link® Thiol Antibody Labeling Kit- Labels 500ug Reference: AT3001-500 Research Use Only Applications: Reactions with Thiol-reactive Groups oYo-Link® Thiol enables the site-specific labeling of oYo-Link®-compatible antibodies with a Thiol to the IgG heavy chain. oYo-Link® Thiol limits the attachment of the thiol labels to the heavy chains of the antibody and therefore ensures that the thiol label does not interfere with antibody binding. Furthermore, site-specific labeling limits 1-2 Thiol labels to be attached per antibody, providing precise antibody-conjugate ratios. The antibody labeling procedure simply requires mixing oYo-Link® Thiol with the desired antibody followed by photocrosslinking with non-damaging black light (365 nm). Photocrosslinking can be carried out in most buffers, including those containing amine-containing molecules (e.g. TRIS, glycine) or storage proteins. (see Buffer Compatibility Table). Requirements: To label your compatible antibodies with oYo-Link®, you will need a Light Source emitting at 365nm (6-10W). Use your own Compatible Device from our list or purchase AlphaThera's LED Photo-Crosslinking Device. Technical Support: For questions concerning compatibility or click-chemistry procedure email support@alphathera.com
Bapotulimab Reference: HY-P99460 Bapotulimab (BAY-1905254) is a fully human IgG2 antibody targeting immunoglobulin-like domain containing receptor 2 (ILDR2). Bapotulimab has antitumor and immunosuppressive effects.
oYo-Link® Thiol Antibody Labeling Kit - Labels 1mg Reference: AT3001-1000 Research Use Only Applications: Reactions with Thiol-reactive Groups oYo-Link® Thiol enables the site-specific labeling of oYo-Link®-compatible antibodies with a Thiol to the IgG heavy chain. oYo-Link® Thiol limits the attachment of the thiol labels to the heavy chains of the antibody and therefore ensures that the thiol label does not interfere with antibody binding. Furthermore, site-specific labeling limits 1-2 Thiol labels to be attached per antibody, providing precise antibody-conjugate ratios. The antibody labeling procedure simply requires mixing oYo-Link® Thiol with the desired antibody followed by photocrosslinking with non-damaging black light (365 nm). Photocrosslinking can be carried out in most buffers, including those containing amine-containing molecules (e.g. TRIS, glycine) or storage proteins. (see Buffer Compatibility Table). Requirements: To label your compatible antibodies with oYo-Link®, you will need a Light Source emitting at 365nm (6-10W). Use your own Compatible Device from our list or purchase AlphaThera's LED Photo-Crosslinking Device. Technical Support: For questions concerning compatibility or click-chemistry procedure email support@alphathera.com
Tabituximab Reference: HY-P99582 Tabituximab (OTSA101) is a humanized monoclonal antibody against frizzled class receptor 10 (FZD10).
oYo-Link® Thiol Antibody Labeling Kit - Labels 100ug mIgG1 Ab Reference: AT3001-mIgG1-100 Research Use Only Applications: Reactions with Thiol-reactive Groups oYo-Link® Thiol enables the site-specific labeling of oYo-Link®-compatible antibodies with a Thiol to the IgG heavy chain. oYo-Link® Thiol limits the attachment of the thiol labels to the heavy chains of the antibody and therefore ensures that the thiol label does not interfere with antibody binding. Furthermore, site-specific labeling limits 1-2 Thiol labels to be attached per antibody, providing precise antibody-conjugate ratios. The antibody labeling procedure simply requires mixing oYo-Link® Thiol with the desired antibody followed by photocrosslinking with non-damaging black light (365 nm). Photocrosslinking can be carried out in most buffers, including those containing amine-containing molecules (e.g. TRIS, glycine) or storage proteins. (see Buffer Compatibility Table). Requirements: To label your compatible antibodies with oYo-Link®, you will need a Light Source emitting at 365nm (6-10W). Use your own Compatible Device from our list or purchase AlphaThera's LED Photo-Crosslinking Device. Technical Support: For questions concerning compatibility or click-chemistry procedure email support@alphathera.com
Iladatuzumab Reference: HY-P99656 Iladatuzumab (MCDS0593A) is a humanized IgG1 anti-human CD79B monoclonal antibody. Iladatuzumab can be used to synthesize antibody-drug conjugates (ADC) Iladatuzumab vedotin (DCDS0780A; HY-P99657), which has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research.
oYo-Link® Thiol Antibody Labeling Kit - Labels 500ug mIgG1 Ab Reference: AT3001-mIgG1-500 Research Use Only Applications: Reactions with Thiol-reactive Groups oYo-Link® Thiol enables the site-specific labeling of oYo-Link®-compatible antibodies with a Thiol to the IgG heavy chain. oYo-Link® Thiol limits the attachment of the thiol labels to the heavy chains of the antibody and therefore ensures that the thiol label does not interfere with antibody binding. Furthermore, site-specific labeling limits 1-2 Thiol labels to be attached per antibody, providing precise antibody-conjugate ratios. The antibody labeling procedure simply requires mixing oYo-Link® Thiol with the desired antibody followed by photocrosslinking with non-damaging black light (365 nm). Photocrosslinking can be carried out in most buffers, including those containing amine-containing molecules (e.g. TRIS, glycine) or storage proteins. (see Buffer Compatibility Table). Requirements: To label your compatible antibodies with oYo-Link®, you will need a Light Source emitting at 365nm (6-10W). Use your own Compatible Device from our list or purchase AlphaThera's LED Photo-Crosslinking Device. Technical Support: For questions concerning compatibility or click-chemistry procedure email support@alphathera.com
Vanucizumab Reference: HY-P99330 Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects.
oYo-Link® Tetrazine Antibody Labeling Kit - Labels 100ug Reference: AT3004-100 Research Use Only Applications: Click Chemistry with TCO (trans-cyclooctene)-bound molecules. oYo-Link® Tetrazine allows for the site-specific labeling of oYo-Link®-compatible antibodies with up to two tetrazine labels per antibody for subsequent copper-free click chemistry reactions with TCO (trans-cyclooctene)-bound molecules. oYo-Link® Tetrazine limits the attachment of the tetrazine labels to the heavy chains of the antibody and therefore ensures that the tetrazine label does not interfere with antibody binding. Furthermore, site-specific labeling limits 1-2 tetrazine labels to be attached per antibody, providing precise antibody-conjugate ratios. The antibody labeling procedure simply requires mixing oYo-Link® Tetrazine with the desired antibody followed by photocrosslinking with non-damaging black light (365 nm). Photocrosslinking can be carried out in most buffers, including those containing amine-containing molecules (e.g. TRIS, glycine) or storage proteins (see Buffer Compatibility Table). Requirements: To label your compatible antibodies with oYo-Link®, you will need a Light Source emitting at 365nm (6-10W). Use your own Compatible Device from our list or purchase AlphaThera's LED Photo-Crosslinking Device. Technical Support: For questions concerning compatibility or click-chemistry procedure email support@alphathera.com
Sevirumab Reference: HY-P99900 Sevirumab (MSL-109) is a human IgG1 neutralizing monoclonal antibody against cytomegalovirus (CMV). Sevirumab recognizes CMV gH complexes and inhibits CMV replication with an EC50 of 0.3 μg/mL.
oYo-Link® Tetrazine Antibody Labeling Kit- Labels 500ug Reference: AT3004-500 Research Use Only Applications: Click Chemistry with TCO (trans-cyclooctene)-bound molecules. oYo-Link® Tetrazine allows for the site-specific labeling of oYo-Link®-compatible antibodies with up to two tetrazine labels per antibody for subsequent copper-free click chemistry reactions with TCO (trans-cyclooctene)-bound molecules. oYo-Link® Tetrazine limits the attachment of the tetrazine labels to the heavy chains of the antibody and therefore ensures that the tetrazine label does not interfere with antibody binding. Furthermore, site-specific labeling limits 1-2 tetrazine labels to be attached per antibody, providing precise antibody-conjugate ratios. The antibody labeling procedure simply requires mixing oYo-Link® Tetrazine with the desired antibody followed by photocrosslinking with non-damaging black light (365 nm). Photocrosslinking can be carried out in most buffers, including those containing amine-containing molecules (e.g. TRIS, glycine) or storage proteins (see Buffer Compatibility Table). Requirements: To label your compatible antibodies with oYo-Link®, you will need a Light Source emitting at 365nm (6-10W). Use your own Compatible Device from our list or purchase AlphaThera's LED Photo-Crosslinking Device. Technical Support: For questions concerning compatibility or click-chemistry procedure email support@alphathera.com